A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)

PHASE3CompletedINTERVENTIONAL
Enrollment

338

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

August 14, 2019

Study Completion Date

September 3, 2020

Conditions
Rheumatoid Arthritis (RA)
Interventions
DRUG

Upadacitinib

Tablets for oral administration

DRUG

Placebo

Tablets for oral administration

Trial Locations (43)

16247

St. Vincent's Hospital /ID# 166918, Suwon

16499

Ajou University Hospital /ID# 163912, Suwon

22332

Inha University Hospital /ID# 163910, Junggu

31151

SoonChunHyang University CheonAn Hospital /ID# 209078, Cheonan-si

35015

Chungnam National University Hospital /ID# 167727, Junggu

41944

Kyungpook National Univ Hosp /ID# 166919, Daegu

61469

Chonnam National University Hospital /ID# 167726, Gwangju

100053

Xuanwu Hosp Capital Med Univ /ID# 161118, Beijing

100730

Peking Union Med College Hosp /ID# 161107, Beijing

130021

The First Hosp of Jilin Univ /ID# 161116, Changchun

200032

Zhongshan Hosp. of Fudan Uni. /ID# 161108, Shanghai

200433

Shanghai Changhai Hospital /ID# 161123, Shanghai

210029

Jiangsu Province Hospital /ID# 161122, Nanjing

213004

The First People's Hospital /ID# 168462, Changzhou

230001

Anhui Provincial Hospital /ID# 161117, Hefei

233099

1st Aff Hosp of Bengbu Med Col /ID# 162161, Bengbu

272001

Jining No.1 People's Hospital /ID# 162158, Jining

300052

Tianjin Med Univ General Hosp /ID# 162155, Tianjin

332000

The First People's Hospital of Jiujiang /ID# 168461, Jiujiang

337055

Pingxiang People's Hospital /ID# 162151, Pingxiang

361003

The 1st Aff Hosp Xiamen Univ /ID# 162154, Xiamen

410000

The Second Xiangya Hospital of Central South University /ID# 162152, Changsha

412007

Zhuzhou Central Hospital /ID# 162153, Zhuzhou

515041

1st Aff Hosp of Shantou Univ /ID# 162165, Shantou Guangdong

610041

West China Hospital /ID# 161119, Chengdu

650032

First Affiliated Hospital of Kunming Medical University /ID# 164637, Kunming

710061

First Affiliated Hospital of Xi'an Jiaotong University /ID# 162150, Xi'an

830001

People's Hospital of Xinjiang /ID# 162157, Ürümqi

80030-110

Ceti - Centro de Estudos Em Terapias Inovadoras Ltda /Id# 152964, Curitiba

87015-000

Parana Medical Research Center /ID# 153507, Maringá

90480-000

LMK Sevicos Medicos S/S /ID# 152963, Porto Alegre

15090-000

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto /ID# 152961, São José do Rio Preto

04266-010

CEPIC - Centro Paulista de Investigação Clínica e Serviços Médicos Ltda /ID# 152966, São Paulo

014016

The First Affiliated Hospital /ID# 163747, Baotou

030001

The Second Hospital of Shanxi /ID# 162164, Taiyuan

02447

Kyung Hee University Medical Center /ID# 163908, Dongdaemun-gu

07061

SMG-SNU Boramae Medical Center /ID# 163911, Dongjak-gu

03722

Yonsei University Health System, Severance Hospital /ID# 168421, Seodaemun-gu

04763

Hanyang University Seoul Hospi /ID# 163913, Seongdong-gu

05030

Konkuk University Medical Ctr /ID# 206148, Seoul

07345

The Catholic University of Korea, Yeouido St. Mary's Hospital /ID# 204224, Seoul

05505

Asan Medical Center /ID# 163909, Seoul

06973

Chung-Ang University Hostipal /ID# 209076, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY